Dr. Boden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
150 S. Huntington Avenue
Boston University School of Medicine and Harvard Medical School
Boston, MA 02130Phone+1 857-364-5613Fax+1 857-364-4424- Is this information wrong?
Summary
- Dr. William E. Boden is Professor of Medicine at Boston University School of Medicine and Lecturer in Medicine, Harvard Medical School, in Boston, Massachusetts. He is the Physician Research Lead for the New England VA Healthcare System and as the Scientific Director of the Clinical Trials Network, which is based at the VA Boston campus. He is also a Senior Investigator at the VA Boston’s Massachusetts Veterans Epidemiology, Research, and Informatics Center (MAVERIC).
Dr. Boden’s principal research interests include studies in ischemic heart disease, post-MI secondary prevention, acute coronary syndromes, and dyslipidemia in post-MI and coronary artery disease (CAD). Dr. Boden has been involved in clinical research investigator activities as the project director, study chairman and co-chairman for multicenter clinical trials, and served as a principal investigator, steering committee member, and consultant for numerous clinical research grant activities funded by the Department of Veterans Affairs, the NIH, and industry. He was the study chairman for the VANQWISH, INTERCEPT, the landmark COURAGE Trial, and more recently, a national co-PI on the NIH-funded ISCHEMIA Trial.
Dr. Boden has lectured widely (both nationally and internationally) and has written over 450 peer-reviewed publications, original articles, books, chapters, and abstracts. He has been selected as one of the Best Doctors in America continuously since 2003. He is a member of several professional Cardiology organizations and editorial boards. He is Deputy Editor for the J. Clin. Lipidology, an Associate Editor of the European Heart Journal Journal and a member of the editorial board of Journal of Cardiovascular Pharmacology and Therapeutics. He serves as an adhoc reviewer for many journals including the N. Engl. J. Med., JAMA, JAMA Cardiol., JACC, Circulation, Am. Heart J., the Lancet, Ann. Intern. Med., Am J. Med., and many others
Education & Training
- Tufts Medical CenterFellowship, Cardiovascular Disease, 1977 - 1979
- Boston University Medical CenterResidency, Internal Medicine, 1974 - 1977
- SUNY Upstate Medical UniversityClass of 1974
Certifications & Licensure
- NY State Medical License 1997 - 2025
- VA State Medical License 2011 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
- Best Doctors in America 2015
- FAHA American Heart Association, 2006
- Join now to see all
Clinical Trials
- Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Start of enrollment: 1998 Dec 01
- Niacin Plus Statin to Prevent Vascular Events Start of enrollment: 2005 Sep 01
Publications & Presentations
PubMed
- The year in cardiovascular medicine 2023: the top 10 papers in ischaemic heart disease.Juan Carlos Kaski, Rasha Al-Lamee, William E Boden> ;European Heart Journal. 2024 Apr 7
- Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States.William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Brandon K Bellows, Catherine G Derington, Sephy Philip, Gabriel Steg...> ;Journal of the American Heart Association. 2024 Jan 2
- 1 citationsIcosapent ethyl for hypertriglyceridaemia and atherosclerosis: greater RESPECT for increased therapeutic use.Prakriti Gaba, Deepak L Bhatt, William E Boden> ;European Heart Journal. 2024 Feb 7
- Join now to see all
Journal Articles
- Association of Sex with Severity of CAD, Ischemia, and Symptom Burden in Patients with Moderate or Severe IschemiaMichael H Picard, Raymond Y Kwong, William E Boden, David J Maron, Judith S Hochman, JAMA Cardiology
Abstracts/Posters
- [Board 372] Association Between Low Baseline Testosterone Levels and Adverse Clinical Outcomes in Men With Established Cardiovascular Disease in the Atherothrombosis I...William Boden, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
Lectures
- The Case for Optimal Medical Therapy First in Most!CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
- Increased Residual Cardiovascular Risk in US Veterans and Monerately-Elevated Baseline Triglycerides and Well-Controlled LDL-C Levels on Statins2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Conservative Management Is Appropriate for Most Elderly Patients With NSTEMI2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Join now to see all
Authored Content
- ACCEL Lite: What Does a Cardiologist Need To Know About Chronic Kidney Disease?June 2023
- Letter by Boden Regarding Article, “Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials”April 2020
- Association of Sex with Severity of CAD, Ischemia, and Symptom Burden in Patients with Moderate or Severe IschemiaMarch 2020
Press Mentions
- Icosapent Ethyl’s CV Mortality Benefit Magnified in Patients with Prior MIApril 25th, 2022
- Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?January 25th, 2022
- Study Estimates How Often People on Medicare May Be Harmed by ‘Low-Value’ CareAugust 19th, 2021
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Veterans Affairs Boston Healthcare SystemWest Roxbury, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: